A study comparing the effectiveness of brimonidine tartrate and timolol eye drops versus a standard combination in patients with glaucoma or ocular hypertension
- Substances:–
Greece- Participants:18–64 years · 65+ years
- Sponsor:OmniVision GmbH
Rare diseases
Investigational molecules
Locations
Lindberghstrasse 9, Puchheim-Bahnhof, 82178, Germany
OmniVision GmbH focuses on glaucoma treatment through clinical research in intraocular pressure control, with attention to patients affected by open-angle glaucoma and related forms of elevated eye pressure.
The sponsor’s research activity in this area is centered on comparative development of generic ophthalmic combinations used in pressure-lowering treatment for chronic glaucoma management.
Clinical trials run by this sponsor – those enrolling participants first.
Greece
GreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.